Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro

Metabolism: Clinical and Experimental
Shulamit MetzgerTova Chajek-Shaul

Abstract

Recombinant human tumor necrosis factor-alpha (TNF) injection in mice was associated with a reduced blood glucose level, already manifest 6 hours following cytokine administration. Insulin levels were not affected. Glycogen content was decreased in a dose-dependent and time-response manner. The activity of glucose-6-phosphatase (G6Pase) was already reduced 6 hours after TNF injection and was sustained 12 hours afterward. Phosphoenolpyruvate carboxykinase (PEPCK) activity was not affected initially (6 hours after injection), but a 50% reduction was observed 12 hours following cytokine administration compared with levels in fasting controls. Both liver G6Pase and PEPCK mRNAs were markedly reduced due to an inhibition of the transcriptional rate. A direct inhibitory effect of TNF on G6Pase promoter activity was demonstrated using HuH-7 cells transiently transfected with G6Pase promoter, fused to a reporter gene.

References

Jan 1, 1992·Proceedings of the Society for Experimental Biology and Medicine·W G Yasmineh, A Theologides
Jun 1, 1991·Metabolism: Clinical and Experimental·C H Lang, C Dobrescu
Apr 15, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·A BurchellB Burchell
Feb 20, 1989·Biochimica Et Biophysica Acta·T Chajek-ShaulY Stein
Feb 1, 1987·Metabolism: Clinical and Experimental·C H LangJ J Spitzer
Jul 1, 1987·The Journal of Clinical Investigation·K R Feingold, C Grunfeld
Dec 1, 1987·Archives of Surgery·R S WarrenM F Brennan
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Dec 1, 1970·Clinica Chimica Acta; International Journal of Clinical Chemistry·F Huijing
Oct 1, 1983·Archives of Biochemistry and Biophysics·D SpagnoliC C Widnell
Nov 30, 1994·Biochemical and Biophysical Research Communications·Z LiuJ Y Chou
Jan 28, 1994·Cell·T KishimotoS Akira
Jul 1, 1993·Proceedings of the Society for Experimental Biology and Medicine·R C NordlieJ D Foster

❮ Previous
Next ❯

Citations

May 19, 2004·The International Journal of Biochemistry & Cell Biology·Stephanie T YerkovichGeorge C T Yeoh
Nov 22, 2000·The Journal of Clinical Investigation·F BenigniR Bucala
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·R S StreeperR M O'Brien
Jan 16, 2013·International Journal of Experimental Pathology·Carolina Campos Lima MoreiraHelenir Medri de Souza
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B ChristA Nath
Apr 4, 2006·Cell Metabolism·Hiroshi InoueMasato Kasuga
Nov 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·J Webber
Oct 23, 2013·Pharmacological Reports : PR·Daniele R MikszaHelenir M de Souza
Oct 16, 2007·Molecular and Cellular Biochemistry·Jennifer WallingtonMichael Alan Titheradge
Sep 11, 2020·Metabolism: Clinical and Experimental·Josiane Érica MiyamotoMarciane Milanski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.